Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2026-03-04 @ 8:18 PM
Study NCT ID:
NCT03165734
Status:
RECRUITING
Last Update Posted:
2025-10-14
First Post:
2017-05-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
Sponsor:
Swedish Orphan Biovitrum
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-26
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-07-30
Completion Date Type:
ESTIMATED
First Submit Date:
2017-05-17
First Submit QC Date:
None
Study First Post Date:
2017-05-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-13
Last Update Post Date:
2025-10-14
Last Update Post Date Type:
ESTIMATED